HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway
Abstract Homeobox B8 (HOXB8) belongs to the HOX family and was essential to the development of colorectal carcinoma. Among the prevalent monoclonal antibodies for treating RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients, cetuximab stands out, but resistance to cetuximab frequently ar...
Saved in:
Main Authors: | Yunan Liang, Han Lin, Zongsheng Jiang, Qi Zhao, Ri Cui, Shaotang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-10-01
|
Series: | Discover Oncology |
Online Access: | https://doi.org/10.1007/s12672-024-01440-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway
by: Yunan Liang, et al.
Published: (2025-01-01) -
Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
by: Shiyun Chen, et al.
Published: (2025-01-01) -
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01) -
Oxaliplatin-Loaded Chitosan Nanoparticles Decorated with Cetuximab Single-Chain Variable Fragment for Human Colorectal Cancer Treatment
by: Khadijeh Falahzadeh, et al.
Published: (2024-09-01) -
Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
by: Nan Zhang, et al.
Published: (2025-02-01)